The major HIF-2α target gene, MET and its ligand hepatocyte growth factor (HGF) are both overexpressed in ccRCC and induces EMT by promoting the expression of beta-Catenin, N-Cadherin and vimentin [150,151,159,160]. The gene discussed is MET; the disease is nonpapillary renal cell carcinoma.